Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.460
-0.020 (-1.35%)
Mar 17, 2026, 4:00 PM EDT - Market closed
Metagenomi Therapeutics Revenue
In the year 2025, Metagenomi Therapeutics had annual revenue of $25.21M, down -51.79%. Metagenomi Therapeutics had revenue of $3.91M in the quarter ending December 31, 2025, a decrease of -59.32%.
Revenue (ttm)
$25.21M
Revenue Growth
-51.79%
P/S Ratio
2.18
Revenue / Employee
$211,849
Employees
119
Market Cap
54.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.21M | -27.09M | -51.79% |
| Dec 31, 2024 | 52.30M | 7.54M | 16.84% |
| Dec 31, 2023 | 44.76M | 27.56M | 160.21% |
| Dec 31, 2022 | 17.20M | 16.96M | 6,978.19% |
| Dec 31, 2021 | 243.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ImmuCell | 27.64M |
| Radiopharm Theranostics | 10.86M |
| GeoVax Labs | 3.35M |
| Lipocine | 1.98M |
| Entera Bio | 124.00K |
MGX News
- 12 days ago - Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results - GlobeNewsWire
- 13 days ago - Metagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 22 days ago - Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference - GlobeNewsWire
- 2 months ago - Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook - GlobeNewsWire
- 3 months ago - Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference - GlobeNewsWire
- 4 months ago - Metagenomi to Present at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 4 months ago - Metagenomi Prioritizes Hemophilia A Program, Lays Off 25% Workforce - Benzinga
- 4 months ago - Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates - GlobeNewsWire